- PSMA can be overexpressed in thymic tumours; - PSMA PET/CT is a whole-body procedure and pitfalls and variants are frequently described in literature; - Radioligand therapies represent a new alternative treatment in advanced prostate cancer patients. Their use in other malignancies could be considered in the near future, if high PSMA expression in those tumours is confirmed
Farolfi, A., Ceci, F., Graziani, T., Lambertini, A., Cervati, V., Basilico, G., et al. (2018). Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient. CLINICAL GENITOURINARY CANCER, n/a, N/A-N/A [10.1016/j.clgc.2018.02.019].
Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient
FAROLFI, ANDREA;Ceci, F.
;Graziani, T.;LAMBERTINI, ALESSANDRO;CERVATI, VERONICA;BRIGANTI, ALBERTO;Castellucci, P.;Fanti, S.
2018
Abstract
- PSMA can be overexpressed in thymic tumours; - PSMA PET/CT is a whole-body procedure and pitfalls and variants are frequently described in literature; - Radioligand therapies represent a new alternative treatment in advanced prostate cancer patients. Their use in other malignancies could be considered in the near future, if high PSMA expression in those tumours is confirmedI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
